Standardized Application of Chinese Patent Medicine in Treatment of Asthma:Interpretation of the Clinical Application Guidelines of Chinese Patent Medicine for Adults with Bronchial Asthma(2021)
Chinese patent medicine(CPM)has been applied to the treatment of asthma widely and built up richer theoretical and practical experience.However,the clinical application of CPM still suffers from unclear efficacy,safety,application indications,and function characteristics,leading to unreasonable and non-standard usage.Evidence-based effectiveness and safety,the full description of instruction including dosage,course,target user,and usage basing syndrome differentiation are the keys to maximizing the curative effect of CPM.In this context,the National Administration of Traditional Chinese Medicine approved the first evidence-based guideline of Clinical Application Guidelines of CPM for Adults with Bronchial Asthma was released in March 2022.Based on the methodology of guidelines and clinical experience,this paper clarifies the particularity and value of CPM in the management of asthma and put forward the research direction.
国家科技期刊平台
NSTL
万方数据
